Krystal Biotech Statistics
NASDAQ: KRYSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
327.30+2.73 (+0.84%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 327.35 +0.02%
Krystal Biotech by the numbers
Krystal Biotech has a market capitalization of $9.69 billion based on 29.60M shares outstanding. Its trailing P/E ratio is 41.0, below the 4-company peer median of 47.3, and its forward P/E is 35.3. The stock trades 3.9% below its 50-day average and 7.9% above its 200-day average.
Average daily trading volume is 381.18K shares, or about $124.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KRYS valuation vs. peer median
| Metric | KRYS | Peer median | Difference |
|---|---|---|---|
| Market cap | $9.69B | $10.24B | -5% |
| P/E (TTM) | 41.0 | 47.3 | -13% |
| Forward P/E | 35.3 | 24.2 | +46% |
| Avg. volume | 381.18K | 2.11M | -82% |
Peer median across 8 companies: PCVX, QGEN, TWST, KYMR, RGEN, IBRX, TECH, HALO.
Valuation
- Market cap
- $9.69B
- P/E (TTM)
- 41.02
- Forward P/E
- 35.33
- Price / sales (latest FY)
- 24.90
- EPS (TTM)
- $7.98
- Shares outstanding
- 29.60M
Price and trading
- Previous close
- 324.57
- Open
- 321.61
- Day range
- 319.58 – 332.11
- 52-week range
- 179.19 – 382.54
- 52-week change
- +74.86%
- 50-day moving average
- 340.41
- 200-day moving average
- 303.20
- Beta
- —
- Volume
- 269.14K
- Average volume
- 381.18K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 9.69B
- Pe
- 41.02
- Forward Pe
- 35.33
- Eps
- 7.98
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 382.54
- Week52 Low
- 179.19
- Avg Volume
- 381.18K
- Shares Outstanding
- 29.60M
- Ma50
- 340.41
- Ma200
- 303.20
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -14.44%
- Pct From52w Low
- 82.66%